- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07036744
Online Acceptance & Compassion Therapy for Body Dysmorphic Disorder - Clinical Trial
This important clinical trial investigates a promising new online group therapy program called Mind-over-Mirror for people struggling with Body Dysmorphic Disorder (BDD). BDD is a serious mental health condition where individuals become extremely preoccupied with perceived flaws in their appearance that others often don't notice. These concerns go far beyond normal appearance worries and can severely impact daily life, often leading to compulsive behaviors like excessive mirror checking or grooming.
The study, conducted by researchers at the University of Coimbra in Portugal, tests an innovative 8-session therapy program that combines two approaches: Acceptance and Commitment Therapy (ACT) and compassion-focused strategies. This program is delivered online in a group format, making it potentially more accessible than traditional in-person therapies. The researchers want to see if this combination can help reduce BDD symptoms more effectively than current treatments while also improving overall quality of life.
Currently, the most common treatments for BDD are medication (like SSRIs) and Cognitive Behavioral Therapy (CBT). While these help many people, they don't work for everyone, and some individuals experience relapses. The Mind-over-Mirror program takes a different approach by teaching participants to:
- Develop self-compassion and reduce shame
- Change their relationship with difficult thoughts about appearance
- Focus on meaningful life activities rather than appearance concerns
- Build psychological flexibility to cope with distressing thoughts and feelings
The study will compare two groups of 16 adults with BDD symptoms: one receiving the therapy immediately and another waiting to receive treatment (acting as a control group). Participants will complete several assessments measuring BDD symptoms, depression, self-compassion, and psychological flexibility at the start, after treatment, and 3 months later. Some participants may also do computer tasks measuring emotional processing while researchers monitor brain activity using a safe, non-invasive technique called fNIRS.
This research is particularly important because BDD is often underdiagnosed and misunderstood. Many people suffer in silence due to shame or because they don't realize their concerns are excessive. The condition can lead to severe distress, social isolation, and even suicidal thoughts. In Portugal, where this study is being conducted, there are currently no validated screening tools or specialized treatments available for BDD.
If successful, this study could pave the way for more accessible, effective treatments for BDD that address not just symptoms but also underlying issues like self-criticism and shame. The online group format could make treatment more affordable and available to people who might avoid in-person therapy due to their appearance concerns. The focus on acceptance and compassion rather than trying to eliminate thoughts about appearance completely may also lead to more lasting improvements than current approaches.
For patients and caregivers, this research offers hope that new treatment options may soon be available. It also highlights the importance of recognizing BDD as a serious mental health condition that deserves attention and specialized care. The study's focus on measuring quality of life improvements, not just symptom reduction, reflects an important shift toward more holistic, patient-centered care in mental health treatment.
Upcoming Clinical Trials
-
NCT07814352RecruitingLeptomeningeal Disease (LMD)
-
NCT07814378Not yet recruitingAnemia | Pregnancy | Iron Deficiency Anaemia in Childbirth
-
NCT07814391Not yet recruitingPeri-Implantitis and Peri-implant Mucositis
-
NCT07814404Not yet recruiting
-
NCT07814417Not yet recruiting
-
NCT07814443Not yet recruiting
-
NCT07814456RecruitingInflammatory Bowel Disease | Ulcerative Colitis (UC)
-
NCT07814495Not yet recruiting
-
NCT07814508RecruitingDiabetes Mellitus | Diabetes Mellitus Type 2 | Sleep Quality | Ecological Momentary Assessment | Continuous Glucose Monitoring System | Diabetes (DM) | Diabetes Distress | Fear of Hypoglycemia | Diabetes Mellitus Type 1 | Glycemic Responses
-
NCT07814534Not yet recruitingParkinson Disease (PD)
-
NCT07814547RecruitingCarpal Tunnel Syndrome (CTS)